Yahoo Canada Web Search

Search results

  1. BeXiMcO synthetics LiMiteD 17, Dhanmondi, Road No. 2, Dhaka-1205 NOTICE OF THE 29TH ANNUAL GENERAL MEETING Notice is hereby given that the 29th Annual General Meeting of the Shareholders of Beximco synthetics limited will be held virtually on Saturday, the 19th December, 2020 at 1.30 p.m. to transact the following business: AGENDA 1.

    • 6MB
    • 56
    • Smart Fabrics
    • 3D Design Solutions
    • Smartlab New York
    • Fighting Covid-19

    One area Beximco has excelled in is its use of “smart fabrics,” or textiles that leverage technology for fashion or design purposes. About 45 percent of apparel companies surveyed by McKinsey in February 2020 are looking to integrate more innovative materials into their products, a trend McKinsey describes as “materials revolution.” Beximco makes u...

    Beximco also utilizes 3D design technology to efficiently showcase samples to clients. The digital solution—developed by fashion design sof tware firms CLO and Browzwear—enables realistic garment simulations. Using the software, designers can make virtual samples, see how the designs fit on models and show them to buyers at different locations, wit...

    Beximco customers in the U.S. can even access the company’s cutting edge technology at its SmartLab in New York. Designers and product developers who visit the SmartLab are able to develop garment washes that fit their requirement on the spot, and digitally transfer their chosen wash recipe to Beximco in Dhaka for bulk production. The company is al...

    The company’s agility and flexibility was put to the test as Covid-19 spread rapidly last year. At the height of pandemic, Beximco quickly pivoted to make fabrics for the manufacture of personal protective equipment (PPE). The company leveraged its existing strengths in technical fabric, sewing and large scale manufacturing to launch Beximco Health...

  2. Mar 25, 2021 · The Bangladeshi company was founded in 1976. Four years later, Beximco Pharmaceuticals started manufacturing products under the licences of Germany-based Bayer and Upjohn of the US, and launched its own formulation brands three years later. In 1985, it was listed on the Dhaka Stock Exchange. Today, Beximco manufactures and markets its own ...

  3. BEXIMCO's corporate mission is "Taking Bangladesh to the world". As BEXIMCO has grown over the years, the flagship platform now has operations and investments across a wide range of industries including textiles, pharmaceuticals, PPE, ceramics, real estate development, construction, trading, marine food, information and communication ...

    • what industries does beximco invest in right now 2020 pictures images 20201
    • what industries does beximco invest in right now 2020 pictures images 20202
    • what industries does beximco invest in right now 2020 pictures images 20203
    • what industries does beximco invest in right now 2020 pictures images 20204
    • what industries does beximco invest in right now 2020 pictures images 20205
  4. Beximco Pharma was founded in 1976 and started operations in 1980, manufacturing products under the licenses of Bayer AG of Germany and Upjohn Inc. of United States. [5] Today, Beximco Pharma manufactures and markets its own branded generics for several diseases including AIDS , cancer , asthma , hypertension , and diabetes for both national and international markets.

  5. Sep 10, 2021 · A survey conducted by McKinsey in April 2020 showed that some 67% of consumers consider the use of sustainable materials to be an important factor when making purchases. “We have some really exciting and revolutionary plans that will reduce the time, energy and effort to bring products to market and at the same time ensure the welfare of our communities and value chain partners.”

  6. People also ask

  7. Jun 30, 2020 · Results for the twelve-month period ended 30 June 2020 Beximco Pharmaceuticals Limited ("Beximco Pharma", "BPL" or "the Company"; AIM Symbol: BXP, LEI No.: 213800IMBBD6TIOQGB56), the fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, today announces its audited results for the twelve months ended ...